Ann: SEQ CEO Interview - 1H18 Results & Outlook, page-3

First 3 Last

Share
Profile

Follow
septic1

554 Posts.

4

02/05/18

14:24

Post #: 32830390
Share

Originally posted by joewolf ↑

Wow a much better and well-presented snapshot of why there are hidden talents with SEQ.

Certainly, think he is better at interviews rather than presentations. Even though my research had highlighted most of that I think there are a few takeouts:

1. Revenue and deferred revenue - The impact of reach and the impact of growth will lock in future profits as the revenue is accrued over the term yet the cashflow accumulates upfront or partially upfront. So maybe the cash flow statement is almost abetter reflection of business performance. Imagine if Harvey Norman was required to defer its income over the life of the TV - lol. Big issue that at the moment is a huge positive.

2. The impact of Interprac is huge and yet we will only see 7 months this year. Hopefully, they will show an annualised impact as well with the full year presentation.

3. Critical mass - that's a real thing within these businesses. They probably need a few bolt-ons to get to the level we need.

4. Paying a dividend for a financial services company is a must and 20% to 50% is more than enough to get rated.

5. Scott Beeton is far better when he just exudes the passion as he talks rather than trying to hit keynotes on a presentation.

6. I respect the guys from Interprac and Garry Crole who was part of the Diversa turnaround so as that got swallowed up into OVH I hope they can hang onto this and keep us all in for the ride. I have topped up recently and am very happy to have done so.

7. I think the message for a grouping of financial services companies is a hard ask as they may serve the same market but have differentiation but over time the ability of the players to assist each other in servicing the market will get through. Its very like selling a professional service it really depends on your people as to what you can do. You can hire a person who can instantly add to your reach and offering.

Now I am looking forward to the full year as that will give us some guidance as to how well this is doing.

Expand

I think SEQ is well placed to benefit from trend away from banks to independents for financial advice..a trend likely to accelerate given the Royal Commission revelations.

SEQ Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Chaos reigns markets – so let's take stock of where we're at ahead of December

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

SHN

Chimeric clocks $4.17M R&D tax rebate from Canberra

OCN

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MTM

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

PME

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

There are more pages in this discussion • 6 more messages in this thread...

First 3 Last

Add SEQ (ASX) to my watchlist

(20min delay)
Last 34.0¢		Change 0.000(0.00%)		Mkt cap ! $48.48M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	50000	33.0¢

Sellers (Offers)

Price($)	Vol.	No.
34.5¢	29697	1

View Market Depth

No.	Vol.	Price($)
1	29291	0.240
1	96902	0.235
1	25000	0.225
1	14191	0.210
1	5000	0.200

Price($)	Vol.	No.
0.255	7487	1
0.270	30000	1
0.275	70000	1
0.295	16666	1
0.300	450000	2

Last trade - 16.16pm 29/11/2024 (20 minute delay)

SEQ (ASX) Chart

Ann: SEQ CEO Interview - 1H18 Results & Outlook, page-3

Top Stories

Chaos reigns markets – so let's take stock of where we're at ahead of December

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Chimeric clocks $4.17M R&D tax rebate from Canberra

Southern Cross Gold zooms in on 9 new high-grade zones above 20g/t at Golden Dyke

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Australian Rare Earths bullish on early-stage uranium potential at Overland, SA

Pro Medicus signs landmark $330M deal to roll out imaging platform in US hospitals

Watchdog takes Webjet to court over alleged 'false' flight prices with hidden fees

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Buyers (Bids)

Sellers (Offers)